Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

Recent research has found that older individuals with a higher intake of caffeinated coffee, particularly the unsweetened ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...

ASAP is now accepting Letters of Intent for the Collaborative Research Network 2025 Scientific Track. This new call is centered around dissecting the mechanisms that can contribute to Parkinson's ...

In Episode 746 of Power Athlete Radio, Dr. Adeel Khan dives into cutting-edge advancements in regenerative medicine, focusing on induced pluripotent stem cells ...

Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Regenerative medicine is an exciting field with a promising future, capable of tackling inherent challenges seen with current therapies.